PEOPLE - FibroGen (US) makes appointment:
This article was originally published in Clinica
Executive Summary
Jack Anthony has been appointed to the new position of vice-president of business development of FibroGen, a US developer of human recombinant collagen for the woundcare market. Mr Anthony joins from Cell Therapeutics, a developer of molecular therapies for cancer, inflammatory and immune diseases.